1. Home
  2. MAN vs ATRC Comparison

MAN vs ATRC Comparison

Compare MAN & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ManpowerGroup

MAN

ManpowerGroup

SELL

Current Price

$41.52

Market Cap

2.5B

ML Signal

SELL

Logo AtriCure Inc.

ATRC

AtriCure Inc.

SELL

Current Price

$56.10

Market Cap

2.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MAN
ATRC
Founded
1948
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.5B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
MAN
ATRC
Price
$41.52
$56.10
Analyst Decision
Buy
Buy
Analyst Count
12
10
Target Price
$52.33
★ $55.78
AVG Volume (30 Days)
★ 991.7K
914.1K
Earning Date
10-15-2026
11-03-2026
Dividend Yield
★ 3.47%
N/A
EPS Growth
N/A
★ 74.74
EPS
★ 1.19
0.18
Revenue
★ $17,957,100,000.00
$201,630,000.00
Revenue This Year
$6.49
$13.42
Revenue Next Year
$3.49
$12.12
P/E Ratio
★ $34.81
$311.17
Revenue Growth
0.58
★ 15.40
52 Week Low
$25.15
$25.36
52 Week High
$63.88
$61.70

Technical Indicators

Market Signals
Indicator
MAN
ATRC
Relative Strength Index (RSI) 20.20 53.78
Support Level $29.25 $26.95
Resistance Level $57.29 $61.70
Average True Range (ATR) 2.52 2.35
MACD -1.23 -0.26
Stochastic Oscillator 3.93 62.26

Price Performance

Historical Comparison
MAN
ATRC

About MAN ManpowerGroup

ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.

About ATRC AtriCure Inc.

AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.

Share on Social Networks: